Evidence map›Paper›PMID 42040021›Full record

ArticleGalen medical journal2024

Examination of A Novel Nanocompositer's Bioactivity for Use in Dentistry : Use of a Novel Nanocompositer's Bioactivity in Dentistry.

Sarvenaz Amanolahi Baharvand, Pardis Chaboki, Fateme Pourhatami, Mohamad Milad Shirvandehi, Reza Yusofvand, Payam Ali -Khiavi, Mohammad Shabestari Khiabani, Khadije Yousefi, Paria Ganji Nataj, Paria Arjmandi Sarvestani and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sarvenaz Amanolahi BaharvandFaculty of Pharmacy, Mazandaran University of Medical Sciences, Mazandaran, Iran.
Pardis ChabokiSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Fateme PourhatamiDepartment of Basic Science, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehrani, Iran.
Mohamad Milad ShirvandehiDepartment of Microbiology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
Reza YusofvandDepartment of Exceptional Talents, Faculty of Medicine Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran.
Payam Ali -KhiaviSchool of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad Shabestari KhiabaniDentistry faculty, Tabriz University of Medical Sciences, Tabriz, Iran.
Khadije YousefiDepartment of Materials Science and Engineering, School of Engineering, Yasouj University, Yasouj, Iran.
Paria Ganji NatajDalian Medical University, Dalian, China.
Paria Arjmandi SarvestaniDepartment of Biomedical Engineering, Faculty of Engineering, Zand Institute of Higher Education, Shiraz, Iran.
Sepideh KarkonshayanStudent Research Committee, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran.
Reza Akhavan-SigariDreifaltigkeits-Hospital Lippstadt, Teaching Hospital of the University of Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extended setting time of mineral trioxide aggregate (MTA) is one of its primary drawbacks. An alternative to MTA, Nano Fast Cement (NFC) is a novel nanocomposite with a quick setting time. In order to develop an exceptional dental filler, hydroxyapatite nanoparticles (NHA) were introduced to NFC to examine its impact on setting time, biocompatibility, and bioactivity qualities. X-ray diffraction, scanning electron microscopy, Gilmore needle, and MTT assay were used to evaluate the specimens with 0, 10, and 20 W% hydroxyapatite. The antibacterial evaluation was conducted using Enterococcus faecalis (PTCC 1394). Using phase and microstructural studies, the production of hydroxyapatite was discovered. Both 10 and 20 weight percent prime apatite enhanced the specimens' bioactivity and markedly decreased their toxicity behavior. More HA content resulted in greater bioactivity enhancement and toxicity decrease. These results suggest that the physical properties of NFC were not negatively impacted by the addition of NHA. In vitro, they enhanced the filler's bioactivity.

Indexed as

BioactivityNanocomposite; Nano Fast CementNano HydroxyapatiteSetting Time

Identifiers

PMID42040021
PMCPMC12107320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.